Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Remco A. Koster"'
Autor:
Gerke Ariaans, Jiske F. Tiersma, Bernardus Evers, Albert Gerding, Stijn J.H. Waaijer, Remco A. Koster, Daan J. Touw, Barbara M. Bakker, Dirk-Jan Reijngoud, Steven de Jong, Mathilde Jalving
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 173, Iss , Pp 116362- (2024)
Reprogrammed metabolism is a hallmark of cancer, but notoriously difficult to target due to metabolic plasticity, especially in response to single metabolic interventions. Combining mTOR inhibitor everolimus and mitochondrial complex 1 inhibitor metf
Externí odkaz:
https://doaj.org/article/82149ce319114b31b253696077747fef
Autor:
Johanna Kuhlin, Marieke G.G. Sturkenboom, Samiksha Ghimire, Ioana Margineanu, Simone H.J. van den Elsen, Noviana Simbar, Onno W. Akkerman, Erwin M. Jongedijk, Remco A. Koster, Judith Bruchfeld, Daan J. Touw, Jan-Willem C. Alffenaar
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 25, Iss , Pp 72- (2022)
Externí odkaz:
https://doaj.org/article/894cb48fe5ff46b78425fa46a9f6371b
Autor:
Stefan P Berger, Remco A. Koster, Stephan J. L. Bakker, Herman Veenhof, Lenneke A T Junier, Daan J Touw
Publikováno v:
Clinical chemistry and laboratory medicine, 58(10), 1687-1695. Walter de Gruyter GmbH
Objectives Monitoring tacrolimus blood concentrations is important for preventing allograft rejection in transplant patients. Our hospital offers dried blood spot (DBS) sampling, giving patients the opportunity to sample a drop of blood from a finger
Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients
Autor:
Marco R. de Groot, Aad P. van den Berg, Remco A. Koster, Stefan P Berger, Jan-Willem C. Alffenaar, Daan J Touw, Stephan J. L. Bakker, Erik A M Verschuuren, Herman Veenhof
Publikováno v:
Clinical chemistry and laboratory medicine, 57(12), 1854-1862. Walter de Gruyter GmbH
Background Monitoring of immunosuppressive drugs such as everolimus and sirolimus is important in allograft rejection prevention in transplant patients. Dried blood spots (DBS) sampling gives patients the opportunity to sample a drop of blood from a
Publikováno v:
Bioanalysis. 11(18):1693-1700
Internal standards (ISs) are essential for the development and use of reliable quantitative bioanalytical LC–MS/MS methods, because they correct for fluctuations in the analytical response that are caused by variations in experimental conditions. S
Publikováno v:
Bioanalysis. 13(6)
Autor:
Daan J Touw, Herman Veenhof, Jan-Willem C. Alffenaar, Kai van Hateren, Pascal Niemeijer, Remco A. Koster
Publikováno v:
Bioanalysis, 11(6), 495-508. FUTURE SCI LTD
AIM: The aim of this study was to develop and validate a LC-MS/MS assay for tacrolimus, sirolimus, everolimus, cyclosporin A and mycophenolic acid using volumetric absorptive microsampling tips as a sampling device and to investigate the effect on th
Autor:
Yngve Bergqvist, Sara Capiau, Constantinos Pistos, Remco A. Koster, Otto Halmingh, Brian G. Keevil, Rafael Linden, Michael Boettcher, Herman Veenhof, Daan J Touw, Christophe P. Stove, Leo M L Stolk, Jan-Willem C. Alffenaar, Birgit C. P. Koch
Publikováno v:
Therapeutic Drug Monitoring, 41(4), 409-430. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring, 41(4), 409-430. Lippincott Williams & Wilkins
Therapeutic Drug Monitoring, 41(4), 409-430. Lippincott Williams & Wilkins
Dried blood spot (DBS) analysis has been introduced more and more into clinical practice to facilitate Therapeutic Drug Monitoring (TDM). To assure the quality of bioanalytical methods, the design, development and validation needs to fit the intended
Autor:
Christina Fawcett, Thijs van Iersel, Remco A Koster, Cathalijne van Doorne, Jocelyn Courville
Publikováno v:
Current reviews in clinical and experimental pharmacology. 17(1)
Background: It has been recognized that patients should be involved in the design of clinical trials. However, there is a lack of agreement on what patient-centricity means. Methods: In this article, a Patient Motivation Pyramid based on Maslow’s t
Autor:
Remco A. Koster
Publikováno v:
Bioanalysis. 12(13)
RA Koster currently works as Associate Director of Bioanalytical Science at the LC–MS/MS department at PRA Health Sciences in the Laboratory in Assen, The Netherlands. He is responsible for the LC–MS/MS analytical method development and leads a t